IL15 and neoplasm: Overexpressing IL-15 or IL-15 receptor complex has been evaluated in CD19-CAR [18], CD123-CAR [87,88], and NKG2D-CAR [89] NK cells, with significantly improved NK cell survival rate and enhanced anti-tumor efficacy.